LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
MDA-MB-231 Sirolimus
3.33
uM
LJP6
 3
L14
 72
hr
 868 2963 3486 0.8499 0.8001
MDA-MB-231 Sorafenib
3.33
uM
LJP6
 1
B08
 72
hr
 868 2806 3486 0.8048 0.7401
MDA-MB-231 Sorafenib
3.33
uM
LJP6
 2
B08
 72
hr
 868 2733 3486 0.7839 0.7123
MDA-MB-231 Sorafenib
3.33
uM
LJP6
 3
B08
 72
hr
 868 2741 3486 0.7862 0.7153
MDA-MB-231 SU11274
3.33
uM
LJP5
 1
J08
 72
hr
 868 2961 3486 0.8493 0.7993
MDA-MB-231 SU11274
3.33
uM
LJP5
 2
J08
 72
hr
 868 3306 3486 0.9483 0.9311
MDA-MB-231 SU11274
3.33
uM
LJP5
 3
J08
 72
hr
 868 3115 3486 0.8935 0.8582
MDA-MB-231 Fedratinib
3.33
uM
LJP5
 1
L02
 72
hr
 868 922 3486 0.2645 0.0206
MDA-MB-231 Fedratinib
3.33
uM
LJP5
 2
L02
 72
hr
 868 946 3486 0.2713 0.0297
MDA-MB-231 Fedratinib
3.33
uM
LJP5
 3
L02
 72
hr
 868 1058 3486 0.3035 0.0725
MDA-MB-231 TGX221
3.33
uM
LJP5
 1
H20
 72
hr
 868 1944 3486 0.5576 0.4109
MDA-MB-231 TGX221
3.33
uM
LJP5
 2
H20
 72
hr
 868 2142 3486 0.6144 0.4865
MDA-MB-231 TGX221
3.33
uM
LJP5
 3
H20
 72
hr
 868 1919 3486 0.5504 0.4014
MDA-MB-231 Torin1
3.33
uM
LJP6
 1
O14
 72
hr
 868 1277 3486 0.3663 0.1562
MDA-MB-231 Torin1
3.33
uM
LJP6
 2
O14
 72
hr
 868 1136 3486 0.3258 0.1023
MDA-MB-231 Torin1
3.33
uM
LJP6
 3
O14
 72
hr
 868 1218 3486 0.3494 0.1336
MDA-MB-231 Torin2
3.33
uM
LJP5
 1
I20
 72
hr
 868 1113 3486 0.3192 0.0935
MDA-MB-231 Torin2
3.33
uM
LJP5
 2
I20
 72
hr
 868 1059 3486 0.3038 0.0729
MDA-MB-231 Torin2
3.33
uM
LJP5
 3
I20
 72
hr
 868 1196 3486 0.3431 0.1252
MDA-MB-231 Tozasertib
3.33
uM
LJP5
 1
B14
 72
hr
 868 1201 3486 0.3445 0.1271
MDA-MB-231 Tozasertib
3.33
uM
LJP5
 2
B14
 72
hr
 868 1089 3486 0.3124 0.0844
MDA-MB-231 Tozasertib
3.33
uM
LJP5
 3
B14
 72
hr
 868 1094 3486 0.3138 0.0863
MDA-MB-231 Trametinib
3.33
uM
LJP5
 1
P20
 72
hr
 868 1089 3486 0.3124 0.0844
MDA-MB-231 Trametinib
3.33
uM
LJP5
 2
P20
 72
hr
 868 1222 3486 0.3505 0.1352
MDA-MB-231 Trametinib
3.33
uM
LJP5
 3
P20
 72
hr
 868 1154 3486 0.3310 0.1092